Endovascular thrombectomy significantly improves the odds of functional independence for stroke patients treated between 24 and 96 hours after symptom onset, according to research published on November 17 in Radiology.
The study, which examined data from eight Chinese stroke centers, suggests that the window for intervention—a critical factor in stroke care—may be wider than previously established clinical guidelines suggest. While standard protocols have historically focused on a 24-hour limit for mechanical clot removal, these findings indicate that a subset of patients may still see meaningful recovery long after that threshold has passed.
Researchers tracked 308 patients to compare outcomes between those who underwent endovascular thrombectomy (EVT) and those who received only the best medical management (BMM). Among the 205 patients who received the procedure, 50.7% achieved functional independence at 90 days. In contrast, only 28.2% of the 103 patients managed with medication alone reached the same milestone, according to the study.
| Outcome at 90 Days | EVT Group | Medical Management Group |
|---|---|---|
| Functional Independence | 50.7% | 28.2% |
| Symptomatic Intracranial Hemorrhage | 5.9% | 2.9% |
| 90-Day Mortality | 11.2% | 13.6% |
Adjusting for multiple variables, the researchers found that patients treated with EVT had 3.8 times better odds of achieving functional independence. Lead authors Tingyu Yi of Fujian Medical University and Lan Hong of Fudan University said that while the safety profile remained favorable, the procedure did carry a higher incidence of any intracranial hemorrhage—23.9% compared to 3.9% in the medical management group.
The findings change how doctors approach the 24-hour treatment window for stroke care. However, experts caution that this does not change the fundamental need for speed in emergency medicine. In an accompanying editorial published alongside the study, Eric Russell of Northwestern University emphasized that the data does not diminish the urgency of rapid identification and treatment.
“Although these results support the adage ‘better late than never’ regarding many patients who will benefit from EVT in ever-later time windows, it should be stressed that these findings do not diminish the importance of rapid identification of stroke and achieving the shortest time from presentation to treatment possible, said Russell.”
The study highlights a recurring tension in modern neurology: the push to extend life-saving interventions to more patients versus the clinical reality that the likelihood of a favorable outcome typically declines as time passes. While the researchers advocate for further evaluation of EVT in carefully selected late-window patients, they also suggest that these findings should be confirmed in randomized trials to fully understand the risk-benefit balance.
For hospitals and health systems, the results raise questions about resource allocation and the necessity of maintaining stroke-ready capabilities around the clock. If the window for successful intervention truly extends to 96 hours, the potential impact on long-term disability rates could be substantial, provided that diagnostic imaging is used effectively to identify salvageable tissue.
The findings are available in the full report published in Radiology.